CANDEL THERAPEUTICS, INC.
Ownership & governance
Executives 5Directors 10Avg age 59Avg tenure 4.7y
PT
Paul-Peter Tak
Chief Executive Officer
Age 66Since 2020-08-31Profile →
+14
Executives5
PT
Paul-Peter Tak→
Chief Executive Officer
Age 66Since 2020-08-31
CS
Charles Schoch→
Director of Finance/CFO
Age 41Since 2024-01-11
WN
William Nichols
Chief Tech/Sci/R&D Officer
Age 57Since 2022-09-11
ST
Seshu Tyagarajan
Chief Tech/Sci/R&D Officer
Age 58Since 2022-03-01
FB
Francesca Barone
Chief Tech/Sci/R&D Officer
Age 49Since 2020-10-31
Board of directors10
EB
Edward Benz→
Director/Board Member
Age 80Since 2017-08-31
PT
Paul-Peter Tak→
Director/Board Member
Age 66Since 2020-08-31
PM
Paul Manning→
Chairman
Age 70Since 2021-07-14
CM
Christopher Martell→
Director/Board Member
Age 47Since 2018-10-31
DN
Diem Nguyen→
Director/Board Member
Age 54Since 2021-07-14
RG
Renee Gaeta→
Director/Board Member
Age 45Since 2022-08-07
JP
Joseph Papa→
Director/Board Member
Age 70Since 2022-08-07
GN
Gary Nabel→
Director/Board Member
Age 72Since 2022-08-07
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Fidelity Management & Research Co. LLC | 15 % | 10,987,017 |
| RTW Investments LP | 8.765 % | 6,422,018 |
| Paul Manning | 7.845 % | 5,748,279 |
| Acorn Capital Advisors LLC | 4.774 % | 3,497,948 |
| BlackRock Advisors LLC | 3.991 % | 2,924,524 |
Catalog · 2026-07-09
Proxy officers21
| Name | Role | Since | Shares |
|---|---|---|---|
| Paul Manning | Chairman | 2021-07-14 | - |
| Charles Schoch | Director or executive officer | — | 158,336 |
| Christopher Martell | Director/Board Member | 2018-10-31 | - |
| Diem Nguyen | Director/Board Member | 2021-07-14 | - |
| Diem Nguyen, Ph.D. M.B.A | Director or executive officer | — | 95,440 |
| Edward Benz | Director/Board Member | 2017-08-31 | - |
| Edward J. Benz, Jr., M.D | Director or executive officer | — | 126,124 |
| Francesca Barone, M.D., Ph.D | Director or executive officer | — | 335,339 |
Proxy · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 21.75Range 15–29Analysts 8
15Mean 21.7529
- Buy 8
Broker actions35
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| B of A Securities | Upgrade | Buy | 18 | 2026-09-21 |
| B of A Securities | Maintained | Neutral | 12 | 2026-08-14 |
| HC Wainwright & Co. | Reiterated | Buy | 23 | 2026-08-13 |
| Stifel | Initiated | Buy | 22 | 2026-07-13 |
| Cantor Fitzgerald | Initiated | Overweight | — | 2026-04-20 |
| Citigroup | Maintained | Buy | 26 | 2026-03-18 |
| Citigroup | Maintained | Buy | 22 | 2026-03-13 |
| Canaccord Genuity | Maintained | Buy | 25 | 2026-03-13 |
| Stephens & Co. | Reiterated | Overweight | 15 | 2025-12-08 |
| Freedom Broker | Maintained | Buy | 14 | 2025-11-21 |
| Citigroup | Maintained | Buy | 24 | 2025-11-14 |
| Stephens & Co. | Initiated | Overweight | 15 | 2025-10-28 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.